English | 繁體

Search in the results

UM

Browse/Search Results:  1-4 of 4 Help

Selected(0)Clear Items/Page:    Sort:
Ganweikang extract protects hepatocytes from oxidative injury by activating Nrf2/HO-1 and MAPKs pathways Journal article
Xiao Linxuan, Zhao Mingming, Linghu Ke-Gang, Wu Guoping, Zhang Tian, Chen Chengyu, Guan Jianli, Cao Zhiming, HU YUANJIA, Yu Hua. Ganweikang extract protects hepatocytes from oxidative injury by activating Nrf2/HO-1 and MAPKs pathways[J]. Fitoterapia, 2024, 178, 106146.
Authors:  Xiao Linxuan;  Zhao Mingming;  Linghu Ke-Gang;  Wu Guoping;  Zhang Tian; et al.
Favorite | TC[WOS]:0 TC[Scopus]:0  IF:2.5/2.7 | Submit date：2024/08/29
Acute Hepatic Injury  Ganweikang  Hepato-protection  Mapks  Nrf2/ho-1  
Rhinitis symptom in patients with self-reported allergic rhinitis is influenced by sensitization pattern: A cross-sectional study of China Journal article
Liting Wu, Teng Zhang, Wenting Luo, Xianhui Zheng, Hong Zhang, Huali Ren, Dongming Huang, Guoping Li, Chunhua Wei, Linghua Dong, Xin Sun, Rongfang Zhang, Yi Wang, Peicun Hu, Yuemin Chen, Qi Zhao, Chuangli Hao, Baoqing Sun. Rhinitis symptom in patients with self-reported allergic rhinitis is influenced by sensitization pattern: A cross-sectional study of China[J]. International Forum of Allergy and Rhinology, 2022, 13(6), 1007-1016.
Authors:  Liting Wu;  Teng Zhang;  Wenting Luo;  Xianhui Zheng;  Hong Zhang; et al.
Favorite | TC[WOS]:2 TC[Scopus]:2  IF:7.2/5.3 | Submit date：2023/01/30
Allergen Sensitization  Allergic Rhinitis  Atopy  Latent Class Analysis  
Prevalence of BRCA1 / BRCA2 pathogenic variation in Chinese Han population Journal article
Dong,Hui, Chandratre,Khyati, Qin,Yue, Zhang,Jing, Tian,Xiaoqing, Rong,Ce, Wang,Ning, Guo,Maoni, Zhao,Guoping, Wang,San Ming. Prevalence of BRCA1 / BRCA2 pathogenic variation in Chinese Han population[J]. Journal of Medical Genetics, 2021, 58(8), 565-569.
Authors:  Dong,Hui;  Chandratre,Khyati;  Qin,Yue;  Zhang,Jing;  Tian,Xiaoqing; et al.
Favorite | TC[WOS]:25 TC[Scopus]:30  IF:3.5/4.1 | Submit date：2021/03/02
Cancer: Breast  Genetics  Molecular Genetics  Oncology  Prevention  
Determination of apatinib and its three active metabolites by UPLC-MS/MS in a Phase IV clinical trial in NSCLC patients Journal article
Guan, Shaoxing, Shi, Wei, Zhao, Zerui, Wang, Fei, Jiang, Fulin, Zhang, Caibin, Jin, Zhongming, Guan, Yanping, Liu, Dihan, Zhong, Guoping, Huang, Min, Long, Hao, Wang, Xueding. Determination of apatinib and its three active metabolites by UPLC-MS/MS in a Phase IV clinical trial in NSCLC patients[J]. Bioanalysis, 2019, 11(22), 2049-2060.
Authors:  Guan, Shaoxing;  Shi, Wei;  Zhao, Zerui;  Wang, Fei;  Jiang, Fulin; et al.
Favorite | TC[WOS]:3 TC[Scopus]:4  IF:1.9/2.1 | Submit date：2022/05/23
Active Metabolites  Apatinib  Therapeutic Drug Monitoring  Uplc-ms/ms